Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

203.34
+0.24000.12%
Pre-market: 201.93-1.4055-0.69%07:44 EDT
Volume:1.48M
Turnover:301.21M
Market Cap:10.45B
PE:32.22
High:205.81
Open:201.84
Low:201.12
Close:203.10
52wk High:217.12
52wk Low:149.09
Shares:51.40M
Float Shares:51.40M
Volume Ratio:0.77
T/O Rate:2.87%
Dividend:0.35
Dividend Rate:0.17%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.28
PE(LYR):5.75

Loading ...

Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)

TIPRANKS
·
Yesterday

Early notable gainers among liquid option names on October 7th

TIPRANKS
·
Yesterday

Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Wednesday

MT Newswires Live
·
Yesterday

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

TIPRANKS
·
Yesterday

StemRIM Wins U.S. Patent for Stem Cell Gene Therapy Targeting Rare Skin Disease

TIPRANKS
·
Yesterday

Gilead : JP Morgan Raises Target Price to $170 from $160

THOMSON REUTERS
·
Yesterday

Moderna Inc. Stock Slips 7.8%, Underperforms Peers

Dow Jones
·
Yesterday

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

TIPRANKS
·
Yesterday

Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools

MT Newswires Live
·
Oct 06

Cognizant announces five-year extension of its work with Gilead Sciences

TIPRANKS
·
Oct 06

Sector Update: Healthcare

MT Newswires Live
·
Oct 06

Cognizant - to Support Gilead's Devops and AI Tools Across Selected Technology Programs

THOMSON REUTERS
·
Oct 06

Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences

THOMSON REUTERS
·
Oct 06

Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors

Reuters
·
Oct 06

Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment to License and Collaboration Agreement - SEC Filing

THOMSON REUTERS
·
Oct 06

Regeneron Pharmaceuticals - Ipr&D Charge Expected to Reduce Q3 2026 Gaap and Non-Gaap EPS by $0.18 - SEC Filing

THOMSON REUTERS
·
Oct 06

Regeneron to Present Phase 3 C-POST Overall Survival Update for Adjuvant Libtayo in High-Risk CSCC at ESMO 2026

Reuters
·
Oct 06

Sanofi Can Move Forward to Pursue Deals

Dow Jones
·
Oct 06

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones
·
Oct 06

Sector Update: Healthcare Stocks Rise Monday Afternoon

MT Newswires Live
·
Oct 06